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Endovascular aneurysm repair is being used increasingly to treat ruptured abdominal aortic aneurysms (RAAAs).
Approximately 25% of RAAAs undergo complete circulatory collapse before or during the procedure. Patient survival
depends on obtaining and maintaining supraceliac balloon control until the endograft is fully deployed. This is accom-
plished with a sheath-supported compliant balloon inserted via the groin contralateral to the side to be used for insertion of
the endograftmain body. After themain body is fully deployed, a second balloon is placedwithin the endograft, and the ﬁrst
balloon is removed so that extension limbs can be placed in the contralateral side. A third balloon can be placed via the
contralateral side and ipsilateral extensions deployed as necessary. This technique of supraceliac balloon control is important
to achieving good outcomes with RAAAs. In addition to minimizing blood loss, this technique minimizes visceral ischemia
and maintains aortic control until the aneurysm rupture site is fully excluded. (J Vasc Surg 2013;57:272-5.)Since 1994, endovascular aneurysm repair (EVAR) has
been used with increasing frequency to treat ruptured
abdominal aortic aneurysms (RAAAs).1-3 Even though
the results of prospective randomized trials comparing
open vs endovascular repair for RAAAs are pending,4,5
retrospective pooled data from several centers around the
world indicate that there is decreased morbidity and
mortality for endovascular repair of RAAAs.6 The technical
success of the endovascular approach hinges on several key
strategies, techniques, and adjuncts.2,6 Approximately 25%
of patients with RAAAs experience complete circulatory
collapse.6 The survival of such patients depends on obtain-
ing and maintaining aortic balloon control continuously
until the endograft is fully deployed and the RAAA is
excluded.7 The technique for doing so is one of many
important steps for achieving good results with EVAR for
RAAA. This article details the steps necessary for effectively
accomplishing supraceliac balloon control in this setting.
TECHNIQUE
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eters, guidewires, and sheaths must be available. With the
patient under local anesthesia, a percutaneous puncture is
made in one common femoral artery, preferably the left. If
the patient has no palpable pulse, ultrasound may be used
to gain access. Alternatively, a small cutdown can be made
to expose the anterior surface of the common femoral
artery. Through this puncture, a ﬂoppy wire, such as
a Bentson wire (Cook Medical, Bloomington, Ind), and
a 7F sheath are placed. An angled catheter is used to navi-
gate the iliac arteries, and a pigtail catheter is placed above
the renal arteries. A cine angiogram may be obtained if
information concerning the aortic neck and iliac arteries
is not available from a preoperative computed tomo-
graphic scan. A Superstiff Lunderquist (Cook Medical)
wire or Meier wire (Boston Scientiﬁc, Natick, Mass) is
inserted into the thoracic aorta, and both the catheter
and the 7F sheath are removed while maintaining digital
control in the groin. Although controversial, to prevent
thrombotic complications, we administer heparin at the
time of large sheath insertion to maintain an activated
clotting time >250 seconds. A 14F  40-cm length
sheath is then placed over the stiff guidewire to a location
well above the renal arteries, and its dilator is removed. A
compliant balloon, such as the Coda balloon (Cook
Medical), is placed under ﬂuoroscopic guidance through
the large sheath to an appropriate level in the suprarenal
aorta (usually above the celiac axis) and inﬂated under
ﬂuoroscopic control until the aorta is occluded. It is
important to ﬁx the sheath in position securely and to
use the distal end of the sheath to support and maintain
the position of the compliant balloon as the blood pres-
sure rises (Fig, A) The sheath should be sutured to the
drapes or skin of the patient, or it should be held manually
because loss of sheath position will make successful
balloon control and removal impossible. This is important
Fig. A, Supraceliac balloon control via a large contralateral sheath. B, Main body of endograft is deployed via ipsilateral
access. Slight temporary deﬂation of the balloon may be required to allow for passage of the tip of the device. C, After
the endograft body and ipsilateral limb are deployed, a second balloon is placed via the ipsilateral groin and inﬂated
within the main body of the graft, maintaining continuous aortic control. D, The contralateral gate is cannulated and
the contralateral limb is deployed while maintaining balloon control from the ipsilateral side. E, To allow for extension
of the ipsilateral limb without losing aortic control, a third balloon is placed through the contralateral groin, main-
taining wire access on the ipsilateral side. F, With the third balloon still inﬂated via the contralateral groin, the ipsilateral
limb is extended to allow for a distal seal. The balloon is then deﬂated and angiography is performed (see text for
details).
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 1 Berland et al 273because the balloon would otherwise migrate distally as
a hypotensive patient’s arterial pressure returns to normal
levels. Femoral access is obtained on the contralateral side
using either open or percutaneous technique. A Bentson
wire, 7F sheath, and angled catheter are used to gain
catheter-guided wire access above the previously placed
aortic control balloon. Slight balloon deﬂation may berequired but usually is unnecessary with proper catheter
support. A Superstiff Lunderquist wire is placed through
this catheter and an angiogram performed through the
large sheath supporting the balloon. After the 7F sheath
and catheter are removed, a properly sized endograft
device (main body) is inserted over the Lunderquist
wire. The tip of the device and its sheath must pass beyond
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under ﬂuoroscopic control and occasionally slight balloon
deﬂation.
By injecting into the contralateral (side with ﬁrst
balloon) sheath, below the balloon, the renal arteries can
be visualized and the most proximal covered portion of
the endograft positioned precisely below their oriﬁces.
The ipsilateral sheath is retracted, deploying the covered
portion of the main body of the endograft along with the
remaining ipsilateral limb. Its delivery system is removed,
leaving the wire and a large sheath in place on that (ipsilat-
eral) side.
A second large, compliant balloon is passed over that
(ipsilateral) wire into the main body of the endograft and
infrarenal aneurysm neck and inﬂated under ﬂuoroscopic
control to occlude aortic ﬂow. The ﬁrst (supraceliac)
balloon is fully deﬂated and removed through its large
contralateral sheath (Fig, C), which had been ﬁxed in place.
At this point, the visceral and renal vessels are perfused.
The contralateral wire and sheath (which are outside
the deployed endograft) are withdrawn into the aneurysm
sac. The contralateral gate is cannulated, and the contralat-
eral limb is placed as in a standard EVAR procedure for an
unruptured AAA. The only difference is that the wire and
tip of the deployment system for the contralateral limb
must be carefully guided above the inﬂated second balloon
in the body of the main graft using the precautions already
described. Using similar techniques, any extensions needed
to obtain a distal seal in the contralateral iliac system are
placed (Fig, D).
If the ipsilateral iliac system has not been sealed, a third
large compliant balloon must be placed in the body of the
graft via the contralateral side and inﬂated within the graft
as the second (ipsilateral) balloon is deﬂated and removed
(Fig, E). With this third balloon maintaining aortic control,
any extensions are placed on the ipsilateral side to obtain
a distal seal, again taking care to pass the tip of any exten-
sion device carefully alongside the balloon without losing
this control. Only when the aneurysm is fully excluded
with appropriate proximal and distal seals should aortic
balloon control be given up and all balloons removed
(Fig, F).
DISCUSSION
EVAR has been used increasingly to treat patients with
RAAAs and offers many theoretical advantages over open
repair. In addition to being less invasive, it eliminates
the complications that can occur during laparotomy, mini-
mizes hypothermia, and can be performed with the patient
under local anesthesia.6,8 Because of these advantages,
many investigators have deemed EVAR to be superior to
open repair for the treatment of RAAAs.2 Combined
results from centers committed to EVAR treatment of
RAAAs indicate that the 30-day mortality for EVAR is
19.7% vs 36.3% for open repair.6 With increasing enthu-
siasm and procedural experience, the more modern series
in the literature attribute lower mortality to several key
strategies, adjuncts, and technical factors.6 These includea standardized approach, hypotensive hemostasis,6 local
anesthesia,8 recognition and treatment of abdominal
compartment syndrome,2 and supraceliac balloon control
of the aorta.7-10 Variations in these techniques may account
for the variable results reported in the literature.6
This article focuses on supraceliac control of the aorta
and describes the transfemoral approach for balloon place-
ment. Others performing this technique have used a trans-
brachial or axillary route for balloon placement. This is
simpler, facilitates balloon ﬁxation, and decreases manipu-
lation within the aortic sac. However, it has the disadvan-
tages of risking injury to the smaller upper extremity
arteries, interfering with C-arm manipulation, and
increasing stroke risk by manipulations near the aortic
arch. One of the advantages of the transfemoral technique
described herein is that it minimizes renal and visceral
ischemia. It is generally well accepted that patients with
longer ischemic times become increasingly acidotic, have
a higher incidence of renal failure, and may have poorer
outcomes. In addition, when done correctly, this technique
provides continuous aortic control until the rupture
site in the aneurysm is sealed. Many patients requiring
balloon control are sufﬁciently ill that they cannot tolerate
loss of this control with further blood loss. Use of an
aortoeuni-iliac endograft may be required if bilateral groin
access is impaired; it also provides rapid exclusion of the
rupture site. However, we favor bifurcated endograft
systems if possible because they provide more dependable
pelvic and extremity revascularization, avoid use of extra-
vascular prosthetic material, and prevent possible-related
complications such as infection. Our technique also allows
rapid balloon control until the rupture site is excluded. In
RAAA cases where the anatomy may be unsuitable for
endovascular repair, this technique of achieving rapid
supraceliac balloon control may also be used to facilitate
open repair.
We have used this technique successfully to maintain
aortic control in 32 patients with RAAAs and circulatory
collapse, and we believe mastery of its technical steps is
crucial for obtaining good outcomes in these patients.
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